Bayer-acquires-Noria-and-PSMA-Therapeutics-to-expand-portfolio-in-prostate-cancer

Broadens company’s oncology platform of Targeted Alpha Therapies / Acquisition includes actinium-225 labeled differentiated PSMA small molecule for the treatment of prostate cancer
Source: Bayer Company News - Category: Pharmaceuticals Source Type: news